Strength and Weaknesses of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease and Possible Detection of Overlaps with Frailty Process

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|12|4|538-546

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.12, Iss.4, 2013-06, pp. : 538-546

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sundowning Syndrome: A Possible Marker of Frailty in Alzheimer’s Disease?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 4, 2013-01 ,pp. : 525-528

Bentham Science Publishers

Access to resources Recommend Favorite

Frailty Among Alzheimer’s Disease Patients

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 4, 2013-06 ,pp. : 507-511

Bentham Science Publishers

Access to resources Recommend Favorite

Aging process, cognitive decline and Alzheimer`s disease: can strength training modulate these responses?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 9, 2015-11 ,pp. : 1209-1213

Bentham Science Publishers

Access to resources Recommend Favorite

Machine Learning and Social Network Analysis Applied to Alzheimer’s Disease Biomarkers

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 5, 2013-03 ,pp. : 652-662

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer’s Disease

By  

Cells Tissues Organs, Vol. 162, Iss. 1, 1998-10 ,pp. : 46-55

Karger

Access to resources Recommend Favorite